Nuclein, LLC

Biotechnology · AUSTIN, TX

BiotechnologySEC Form D

Nuclein, LLC filed a Form D with the U.S. Securities and Exchange Commission on June 22, 2026, reporting $1,295,000 raised toward a $11,114,842 offering.

Incorporated in Texas and based in AUSTIN, TX, it operates in the Biotechnology sector.

Companies file a Form D within 15 days of the first sale of securities in a private offering under Regulation D — an early, public signal that Nuclein, LLC has raised capital from private investors.

Browse more recently funded companies in Biotechnology.

Executives & Directors

  • Alan BlakeExecutive Officer · Director
  • Richard CrockettDirector
  • William CunninghamDirector
  • Douglas BryantDirector
  • Sanjay ChandraDirector
  • H. David ShockleyDirector
  • Walter NarajowskiDirector
  • Jeffrey StukulsExecutive Officer

Recently funded in Biotechnology

Other companies that recently filed a Form D

$19.1MRaised

Rapalogix Health, Inc.

BiotechnologyCARLSBAD, CA
Jun 22, 2026View SEC Form D
$150.0KRaised

Chickadee Biomedicines, Inc.

BiotechnologyBOSTON, MA
Jun 22, 2026View SEC Form D
$500.0KRaised

Boston Interactome, Inc.

BiotechnologyALLSTON, MA
Jun 18, 2026View SEC Form D
$3.8MRaised

DINYA DNA, Inc.

BiotechnologyOAKLAND, CA
Jun 18, 2026View SEC Form D
$6.5MRaised

REGENTIS BIOMATERIALS LTD.

BiotechnologyHERZLIYA, L3
Jun 17, 2026View SEC Form D